glp-1 agonist and dpp-4 inhibitor Comparison of receptor agonists inhibitors The effect of DPP-4 inhibitors,
Description
A clinical trial in 2015 linked an undisclosed GLP-1 to significant improvements in OSA severity, while a 2016 clinical trial found that weight loss resulting from liraglutide was significantly associated with a reduction in the apnea-hypopnea index (AHI)

The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus

How are the drugs administered

Women with active IIH were identified and recruited from a single tertiary referral hospital (Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, United Kingdom)

523 Not only hepatocellular carcinoma, but GLP-1 has also shown potential in the treatment of other gastrointestinal tumors

Open Cardiovasc
